TickerFacts.

Progyny, Inc. (PGNY): Gross Profit

Annual figures by period end, from SEC filings.

$304.48M
Year ended 2025-12-31
$322.09M
Trailing 12 months to 2026-06-30
+22.1%
3-year compound annual growth
+34.2%
5-year compound annual growth
2017-12-31: $7.40M2018-12-31: $19.43M2019-12-31: $45.51M2020-12-31: $70.06M2021-12-31: $112.14M2022-12-31: $167.32M2023-12-31: $238.80M2024-12-31: $253.36M2025-12-31: $304.48M$304.48M
2017-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$304.48M+20.2%2026-02-27, From 2025-01-01
2024-12-31$253.36M+6.1%2026-02-27, From 2024-01-01
2023-12-31$238.80M+42.7%2026-02-27, From 2023-01-01
2022-12-31$167.32M+49.2%2025-03-03, From 2022-01-01
2021-12-31$112.14M+60.1%2024-02-29, From 2021-01-01
2020-12-31$70.06M+54.0%2023-03-01, From 2020-01-01
2019-12-31$45.51M+134.2%2022-03-01, From 2019-01-01
2018-12-31$19.43M+162.6%2021-03-01, From 2018-01-01
2017-12-31$7.40Mn/a2020-03-10, From 2017-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Progyny, Inc. (PGNY)2025-12-31$304.48M+20.2%
Sotera Health Co (SHC)2025-12-31$645.53M+7.2%
Viemed Healthcare, Inc. (VMD)2025-12-31$155.46M+16.7%
Cryo Cell International Inc (CCEL)2025-11-30$24.19M+0.6%
Mangoceuticals, Inc. (MGRX)2025-12-31$250.4K-34.1%
BioRestorative Therapies, Inc. (BRTX)2025-12-31$335.9K-9.9%

Compare PGNY, SHC, VMD, CCEL side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗